Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB26FQAAS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,249
Award facts
- Contract value 100% obligated
- $6,248.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $6,248.79 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 68 mg Nexplanon implants. The delivery order, issued on November 6, 2025, with an ultimate completion date of December 1, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring pharmaceutical and medical supply needs of Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, holding a single-award IDC designated as contract SPE2DR with a ceiling value of $499,999,999 and completion date of December 31, 2036. The company's extensive product portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, enabling it to fulfill diverse pharmaceutical requirements for military healthcare operations globally. The contractor has demonstrated substantial federal contracting activity through numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division, positioning it as a key regional prime vendor contractor supporting DOD medical operations.
Quick answers
Who was awarded contract SPE2DB26FQAAS?
SPE2DB26FQAAS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FQAAS worth?
The government has obligated $6,249 on SPE2DB26FQAAS.
Is contract SPE2DB26FQAAS an order under another contract?
Yes. SPE2DB26FQAAS is a delivery order under SPE2DB25D9305, an indefinite delivery contract.
Was contract SPE2DB26FQAAS competed?
The extent of competition for SPE2DB26FQAAS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award